MedTrace Logo

Cervical Spinal Cord Stimulation for the Prevention of Cerebral Vasospasm

NCT00766844 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-01-23

No results posted yet for this study

Summary

The study investigates safety, feasibility and effectiveness of cervical spinal cord stimulation (SCS) in prevention of cerebral arterial vasospasm following aneurysmal subarachnoid hemorrhage (aSAH).

It is postulated that 2 week long stimulation of the cervical spinal cord using an implanted epidural electrode will prevent or decrease severity of cerebral arterial vasospasm following aSAH.

Conditions

  • Aneurysmal Subarachnoid Hemorrhage

Interventions

DEVICE

spinal cord stimulation

electrode is inserted into cervical epidural space for continuous spinal cord stimulation

Sponsors & Collaborators

  • Konstantin V. Slavin

    lead OTHER

Principal Investigators

  • Konstantin V Slavin, MD · University of Illinois at Chicago

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00766844 on ClinicalTrials.gov